Centre for Integrated Preclinical Drug Development

The Centre for Integrated Preclinical Drug Development (CIPDD) in the Faculty of Medicine has state-of-the-art physical infrastructure located in NATA-accredited facilities on the St Lucia and Herston Campuses of The University of Queensland (UQ).

NATA Accredited Facility

CIPDD’s GLP recognition by the National Association of Testing Authorities (NATA) means that data from our in vivo toxicology studies undertaken in support of the TetraQ RIC will be accepted for review when included in submissions to international regulatory agencies.

Our partners

Small Molecule Drug Discovery

Small Molecule Drug Discovery

The CIPDD (Centre for Integrated Preclinical Drug Development) is part of an integrated capability network of National Research Infrastructure that supports Small Molecule Drug Discovery. These facilities provide expertise and infrastructure to support leading-edge research and boost innovation across Australia. For more information, visit Therapeutic Innovation Australia's Pipeline Navigator for an interactive map of translational capabilities accessible to researchers.

TIA logo      NCRIS logo

Contact

Professor Maree Smith

T: +61 7 3365 2554
F: +61 7 3346 7391
Emaree.smith@uq.edu.au

Mailing/Delivery Address
Level 3 Steele Building, St. Lucia campus, Staffhouse Rd,

The University of Queensland
Brisbane Qld 4072 
Australia

Meet our team